Skip to main navigation Skip to search Skip to main content

Thiamine deficiency in hematologic malignant tumors

  • H. C. T. van Zaanen*
  • , J. van der Lelie
  • *Corresponding author for this work
  • Amsterdam UMC - University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The case is reported of a patient with acute myeloid leukemia with severe right‐sided congestive heart failure that responded to treatment with thiamine. Leukocytes cells contain relatively high concentrations of thiamine‐dependent enzymes compared with erythrocytes. Because no other cause could be found, it was postulated that consumption of thiamine by blast cells was responsible for the deficiency. After studying this patient, the thiamine pyrophosphate (TPP) effect was measured in five other consecutive patients with fast‐growing hematologic malignant tumors. In two patients, the TPP effect was elevated slightly, but another patient had a definite thiamine deficiency with severe cardiac failure. It is suggested that the clinician be alert for this underdiagnosed potentially fatal but easily treatable deficiency in nonalcoholic patients with fast‐growing hematologic cancers. Copyright © 1992 American Cancer Society
Original languageEnglish
Pages (from-to)1710-1713
JournalCancer
Volume69
Issue number7
DOIs
Publication statusPublished - 1992
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Thiamine deficiency in hematologic malignant tumors'. Together they form a unique fingerprint.

Cite this